# Anngeen

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/anngeen

- Industry: Biotechnology
- Headquarters: Beijing, China
- Total disclosed funding: $11M
- Latest round: Series A (Jul 11, 2018)
- Investors on record: 1

## About

Based in Beijing, China and established in 2017, Anngeen operates as a biotechnology company that focuses on providing disease detection services for clinical medicine via utilizing gene-sequencing technology.

## Funding rounds

- Series A, Jul 11, 2018, $11M — LYFE Capital

## Investors

- LYFE Capital — Series A